S&P Removes Valeant Pharma (VRX) from CreditWatch Positive; Ratings Affirmed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
UPDATE: Valeant's (VRX) Plaque Psoriasis Injection Faces July 19th FDA Panel
June 9, 2016 9:14 AM EDT(Updated - June 9, 2016 9:19 AM EDT)
Valeant Pharma's (NYSE: VRX) plaque psoriasis injection faces July 19th FDA panel, according to Bloomberg.
UPDATE - The HHS document is embedded below:
... More